Showing results (31-40 of 55) with videos related to
Sort By:
Pageof 6
Virchows Archiv : an International Journal of Pathology|November 23, 2006
Analysis of glomerular VEGF mRNA and protein expression in murine mesangioproliferative glomerulonephritisChristian S Haas, Valentina Câmpean, Alexander Kuhlmann, et al.The EMBO Journal|January 13, 2011
The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cellsSimone Brabletz, Karolina Bajdak, Simone Meidhof, et al.Advances in Medical Sciences|May 7, 2014
Gastric cancer patients less than 50 years of age exhibit significant downregulation of E-cadherin and CDX2 compared to older reference populationsClaus Wilhelm Schildberg, Mohammed Abba, Susanne Merkel, et al.The Journal of Surgical Research|September 6, 2003
P27 does not predict histopathological response to radiochemotherapy in rectal cancerKlaus Günther, Arno Dimmler, Franz Rödel, et al.Journal of Biomedicine & Biotechnology|October 15, 2009
Comparability of microarray data between amplified and non amplified RNA in colorectal carcinomaRoland S Croner, Berthold Lausen, Vera Schellerer, et al.Cancer Research|January 18, 2008
The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancerSimone Spaderna, Otto Schmalhofer, Mandy Wahlbuhl, et al.Anticancer Research|April 1, 2009
Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastasesBernhard Gentner, Axel Wein, Roland S Croner, et al.Breast Cancer Research : BCR|July 17, 2008
The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancerNuran Bektas, Erik Noetzel, Jürgen Veeck, et al.Cancer Research|February 20, 2004
Beta-catenin up-regulates the expression of the urokinase plasminogen activator in human colorectal tumorsElke Hiendlmeyer, Susanne Regus, Stella Wassermann, et al.International Journal of Cancer|August 13, 2008
Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapyElisabeth Naschberger, Roland S Croner, Susanne Merkel, et al.Pageof 6